$161m loss on North America impairment as EBITDA fell 35%

Strip out the impairment and the operating picture is still weaker: EBITDA fell to $39.0m from $59.6m (down 34.6%) on revenue that was broadly flat at $195.2m versus $194.4m (a basis-discontinuity caveat applies to the revenue growth percentage). ARR eased 0.5% to $174.3m, and operating cash flow fell to $30.3m from $43.2m.

Free cash flow to the firm dropped to $0.1m from $16.0m as capex nearly doubled to $25.2m (12.9% of revenue versus 6.9% prior) on the 4G upgrade program; management quotes a normalised FCF of $14.4m. By region, Australia grew from $13.7m to $18.8m, North America fell from $81.2m to $74.4m, and New Zealand eased to $102.0m. Total assets fell to $308.8m from $460.3m, reflecting the write-down.

The non-cash impairment is the dominant FY26 item and it lands on a segment whose revenue fell from $81.2m to $74.4m and contribution from $17.7m to $15.0m. The impairment changes the carrying value, but the underlying trajectory is the read: this region is now smaller (38.1% of group revenue versus 41.8%) and its growth profile is the open strategic question.

Operating margin has stepped down materially. EBITDA margin fell to 20.0% from 30.7%, sitting below the company's recent historical range of 25.8%–30.7% (mean 28.6%). On essentially flat revenue, this is not a mix story alone — it implies underlying cost growth or hardware/service economics that did not move with the top line. The size of the step matters because it sets the FY27 starting point.

Cash generation has narrowed but capex intent is explained. FCF to the firm fell to $0.1m from $16.0m as capex hit 12.9% of revenue. Management attributes the spike to the 4G upgrade and frames it as temporary, but the supplied excerpts do not state when capex intensity reverts to a normalised level.

Management language points to "significant improvement being targeted" without quantification. Against the supplied half-year context, H1 FY26 FCF to the firm was $6.2m versus full-year $0.1m, implying second-half cash generation was negative — consistent with capex weighting through the year but a useful checkpoint when H1 FY27 prints.

With no stated target to benchmark against, the read is the gap between the current 20.0% EBITDA margin and the company's recent 25.8%–30.7% historical range. Recovering that range without revenue growth would require explicit cost actions that the release does not detail, so the bridge to "significant improvement" is not yet substantiated.

The impairment does not affect cash flow, net debt of $16.0m to EBITDA at 0.41x sits within the supplied historical range, and NTA per share at $0.25 (versus $0.31) absorbs the write-down on a still-conservative balance sheet. Operating working-capital movement and debtor days are within recent norms, so cash quality has not been propped up by receivables stretching.

The underlying earnings story is weaker. EBITDA fell 34.6% on flat revenue, so the decline cannot be explained by deferred-revenue or implementation timing alone, and ARR slipping 0.5% indicates recurring revenue quality is not improving. Reported OCF/EBITDA cash conversion sits within the company's recent historical pattern (a basis-discontinuity caveat applies to that ratio), but the absolute FCF outcome of $0.1m depends entirely on whether 4G capex is genuinely one-off. Management calls it temporary; the release does not commit to a duration.

This briefing cannot assess the durability of the FY26 EBITDA step-down without segment-level cost disclosure or management quantification of the 4G program duration.